EW logo

EW Cash From Operations

Annual CFO:

$542.30M-$353.50M(-39.46%)
December 31, 2024

Summary

  • As of today, EW annual cash from operations is $542.30 million, with the most recent change of -$353.50 million (-39.46%) on December 31, 2024.
  • During the last 3 years, EW annual cash from operations has fallen by -$1.19 billion (-68.69%).
  • EW annual cash from operations is now -68.69% below its all-time high of $1.73 billion, reached on December 31, 2021.

Performance

EW Cash From Operations Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherEWcash flow metrics

Quarterly CFO:

$573.70M+$283.50M(+97.69%)
September 30, 2025

Summary

  • As of today, EW quarterly cash from operations is $573.70 million, with the most recent change of +$283.50 million (+97.69%) on September 30, 2025.
  • Over the past year, EW quarterly cash from operations has increased by +$221.90 million (+63.08%).
  • EW quarterly cash from operations is now -26.26% below its all-time high of $778.00 million, reached on June 30, 2014.

Performance

EW Quarterly Cash From Operations Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherEWcash flow metrics

TTM CFO:

$1.02B+$221.90M(+27.92%)
September 30, 2025

Summary

  • As of today, EW TTM cash from operations is $1.02 billion, with the most recent change of +$221.90 million (+27.92%) on September 30, 2025.
  • Over the past year, EW TTM cash from operations has increased by +$210.40 million (+26.09%).
  • EW TTM cash from operations is now -42.18% below its all-time high of $1.76 billion, reached on September 30, 2021.

Performance

EW TTM Cash From Operations Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherEWcash flow metrics

Cash From Operations Formula

CFO = Net Income + Non Cash Expenses + Changes In Working Capital

EW Cash From Operations Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterlyTTMTTM
1Y1 Year-39.5%+63.1%+26.1%
3Y3 Years-68.7%+85.1%-22.3%
5Y5 Years-54.0%+165.5%-3.5%

EW Cash From Operations Highs & Lows

PeriodPeriodAnnual vs HighAnnual vs HighAnnual vs LowAnnual vs LowQuarter. vs HighQuarter. vs HighQuarter. vs LowQuarter. vs LowTTM vs HighTTM vs HighTTM vs LowTTM vs Low
3Y3-Year-68.7%at lowat high+550.0%-22.3%+92.5%
5Y5-Year-68.7%at lowat high+550.0%-42.2%+92.5%
All-TimeAll-Time-68.7%+436.9%-26.3%+550.0%-42.2%+6678.7%

EW Cash From Operations History

DateAnnualQuarterlyTTM
Sep 2025
-
$573.70M(+97.7%)
$1.02B(+27.9%)
Jun 2025
-
$290.20M(+3.5%)
$794.90M(-9.3%)
Mar 2025
-
$280.40M(+319.9%)
$876.20M(+61.6%)
Dec 2024
$542.30M(-39.5%)
-$127.50M(-136.2%)
$542.30M(-32.8%)
Sep 2024
-
$351.80M(-5.3%)
$806.40M(-6.9%)
Jun 2024
-
$371.50M(+794.4%)
$866.10M(+64.0%)
Mar 2024
-
-$53.50M(-139.2%)
$528.20M(-41.0%)
Dec 2023
$895.80M(-26.5%)
$136.60M(-66.8%)
$895.80M(-14.0%)
Sep 2023
-
$411.50M(+1124.7%)
$1.04B(+10.8%)
Jun 2023
-
$33.60M(-89.3%)
$940.40M(-24.1%)
Mar 2023
-
$314.10M(+11.1%)
$1.24B(+1.7%)
Dec 2022
$1.22B(-29.7%)
$282.80M(-8.7%)
$1.22B(-6.9%)
Sep 2022
-
$309.90M(-6.7%)
$1.31B(-14.5%)
Jun 2022
-
$332.20M(+13.3%)
$1.53B(-11.2%)
Mar 2022
-
$293.30M(-21.5%)
$1.72B(-0.4%)
Dec 2021
$1.73B(+64.3%)
$373.60M(-29.8%)
$1.73B(-1.5%)
Sep 2021
-
$531.90M(+1.1%)
$1.76B(+21.9%)
Jun 2021
-
$526.10M(+75.1%)
$1.44B(+25.7%)
Mar 2021
-
$300.50M(-24.9%)
$1.15B(+8.9%)
Dec 2020
$1.05B(-10.6%)
$400.00M(+85.1%)
$1.05B(+0.1%)
Sep 2020
-
$216.10M(-6.5%)
$1.05B(-17.4%)
Jun 2020
-
$231.20M(+11.7%)
$1.27B(-7.9%)
Mar 2020
-
$207.00M(-48.2%)
$1.38B(+17.4%)
Dec 2019
$1.18B(+27.3%)
$399.40M(-8.7%)
$1.18B(+9.9%)
Sep 2019
-
$437.30M(+28.2%)
$1.07B(+9.7%)
Jun 2019
-
$341.20M(>+9900.0%)
$978.00M(+25.9%)
Mar 2019
-
$1.50M(-99.5%)
$777.00M(-16.2%)
Dec 2018
$926.80M(-7.4%)
$293.00M(-14.4%)
$926.80M(-7.1%)
Sep 2018
-
$342.30M(+144.2%)
$997.70M(+3.3%)
Jun 2018
-
$140.20M(-7.3%)
$966.20M(-5.6%)
Mar 2018
-
$151.30M(-58.4%)
$1.02B(+2.3%)
Dec 2017
$1.00B(+42.1%)
$363.90M(+17.1%)
$1.00B(+19.4%)
Sep 2017
-
$310.80M(+57.2%)
$837.90M(+14.3%)
Jun 2017
-
$197.70M(+54.1%)
$733.00M(+1.0%)
Mar 2017
-
$128.30M(-36.2%)
$725.60M(+3.0%)
Dec 2016
$704.40M(+28.1%)
$201.10M(-2.3%)
$704.40M(+16.0%)
Sep 2016
-
$205.90M(+8.2%)
$607.10M(+0.6%)
Jun 2016
-
$190.30M(+77.7%)
$603.70M(+3.5%)
Mar 2016
-
$107.10M(+3.2%)
$583.50M(+6.1%)
Dec 2015
$549.70M(-46.2%)
$103.80M(-48.7%)
$549.70M(+2.0%)
Sep 2015
-
$202.50M(+19.0%)
$539.10M(+54.6%)
Jun 2015
-
$170.10M(+132.1%)
$348.80M(-63.5%)
Mar 2015
-
$73.30M(-21.4%)
$956.70M(-6.4%)
Dec 2014
$1.02B(+116.3%)
$93.20M(+663.9%)
$1.02B(-1.7%)
Sep 2014
-
$12.20M(-98.4%)
$1.04B(-11.5%)
Jun 2014
-
$778.00M(+460.1%)
$1.18B(+124.2%)
Mar 2014
-
$138.90M(+24.8%)
$524.30M(+10.9%)
Dec 2013
$472.70M(+26.5%)
$111.30M(-24.3%)
$472.70M(-3.1%)
Sep 2013
-
$147.10M(+15.8%)
$487.80M(+3.3%)
Jun 2013
-
$127.00M(+45.5%)
$472.00M(-4.0%)
Mar 2013
-
$87.30M(-30.9%)
$491.80M(+31.6%)
Dec 2012
$373.80M
$126.40M(-3.7%)
$373.80M(-4.3%)
DateAnnualQuarterlyTTM
Sep 2012
-
$131.30M(-10.6%)
$390.50M(+9.6%)
Jun 2012
-
$146.80M(+578.2%)
$356.40M(+32.5%)
Mar 2012
-
-$30.70M(-121.5%)
$268.90M(-14.5%)
Dec 2011
$314.50M(+25.1%)
$143.10M(+47.2%)
$314.50M(+18.5%)
Sep 2011
-
$97.20M(+63.9%)
$265.40M(+0.3%)
Jun 2011
-
$59.30M(+298.0%)
$264.60M(+4.5%)
Mar 2011
-
$14.90M(-84.1%)
$253.30M(+0.8%)
Dec 2010
$251.40M(+52.1%)
$94.00M(-2.5%)
$251.40M(+12.6%)
Sep 2010
-
$96.40M(+100.8%)
$223.30M(+12.6%)
Jun 2010
-
$48.00M(+269.2%)
$198.40M(-7.4%)
Mar 2010
-
$13.00M(-80.3%)
$214.30M(+29.6%)
Dec 2009
$165.30M(+7.9%)
$65.90M(-7.8%)
$165.30M(-8.1%)
Sep 2009
-
$71.50M(+11.9%)
$179.90M(+47.2%)
Jun 2009
-
$63.90M(+277.5%)
$122.20M(+40.0%)
Mar 2009
-
-$36.00M(-144.7%)
$87.30M(-43.0%)
Dec 2008
$153.20M(-27.1%)
$80.50M(+483.3%)
$153.20M(+2.4%)
Sep 2008
-
$13.80M(-52.4%)
$149.60M(-23.4%)
Jun 2008
-
$29.00M(-3.0%)
$195.20M(-4.3%)
Mar 2008
-
$29.90M(-61.1%)
$204.00M(-2.9%)
Dec 2007
$210.20M(-8.9%)
$76.90M(+29.5%)
$210.20M(+3.4%)
Sep 2007
-
$59.40M(+57.1%)
$203.30M(-0.4%)
Jun 2007
-
$37.80M(+4.7%)
$204.10M(-0.9%)
Mar 2007
-
$36.10M(-48.4%)
$205.90M(-10.8%)
Dec 2006
$230.80M(+68.7%)
$70.00M(+16.3%)
$230.80M(+12.5%)
Sep 2006
-
$60.20M(+52.0%)
$205.10M(+11.5%)
Jun 2006
-
$39.60M(-35.1%)
$183.90M(+4.0%)
Mar 2006
-
$61.00M(+37.7%)
$176.90M(+29.3%)
Dec 2005
$136.80M(-24.3%)
$44.30M(+13.6%)
$136.80M(-4.6%)
Sep 2005
-
$39.00M(+19.6%)
$143.40M(-12.9%)
Jun 2005
-
$32.60M(+56.0%)
$164.70M(+0.2%)
Mar 2005
-
$20.90M(-58.9%)
$164.30M(-9.0%)
Dec 2004
$180.60M(+47.7%)
$50.90M(-15.6%)
$180.60M(-8.8%)
Sep 2004
-
$60.30M(+87.3%)
$198.10M(+20.6%)
Jun 2004
-
$32.20M(-13.4%)
$164.20M(-2.3%)
Mar 2004
-
$37.20M(-45.6%)
$168.10M(+37.4%)
Dec 2003
$122.30M(+1.4%)
$68.40M(+159.1%)
$122.30M(+21.0%)
Sep 2003
-
$26.40M(-26.9%)
$101.10M(-4.1%)
Jun 2003
-
$36.10M(+519.8%)
$105.40M(-6.6%)
Mar 2003
-
-$8.60M(-118.2%)
$112.90M(-6.4%)
Dec 2002
$120.60M(+19.4%)
$47.20M(+53.7%)
$120.60M(+0.6%)
Sep 2002
-
$30.70M(-29.6%)
$119.90M(+1.9%)
Jun 2002
-
$43.60M(+4944.4%)
$117.70M(+9.6%)
Mar 2002
-
-$900.00K(-101.9%)
$107.40M(+6.3%)
Dec 2001
$101.00M(-26.3%)
$46.50M(+63.2%)
$101.00M(-2.9%)
Sep 2001
-
$28.50M(-14.4%)
$104.00M(-11.9%)
Jun 2001
-
$33.30M(+556.2%)
$118.00M(+2.9%)
Mar 2001
-
-$7.30M(-114.7%)
$114.70M(-16.3%)
Dec 2000
$137.00M(-22.2%)
$49.50M(+16.5%)
$137.00M(+56.6%)
Sep 2000
-
$42.50M(+41.7%)
$87.50M(+94.4%)
Jun 2000
-
$30.00M(+100.0%)
$45.00M(+200.0%)
Mar 2000
-
$15.00M
$15.00M
Dec 1998
$176.00M(+8.0%)
-
-
Dec 1997
$163.00M
-
-

FAQ

  • What is Edwards Lifesciences Corporation annual cash from operations?
  • What is the all-time high annual cash from operations for Edwards Lifesciences Corporation?
  • What is Edwards Lifesciences Corporation annual cash from operations year-on-year change?
  • What is Edwards Lifesciences Corporation quarterly cash from operations?
  • What is the all-time high quarterly cash from operations for Edwards Lifesciences Corporation?
  • What is Edwards Lifesciences Corporation quarterly cash from operations year-on-year change?
  • What is Edwards Lifesciences Corporation TTM cash from operations?
  • What is the all-time high TTM cash from operations for Edwards Lifesciences Corporation?
  • What is Edwards Lifesciences Corporation TTM cash from operations year-on-year change?

What is Edwards Lifesciences Corporation annual cash from operations?

The current annual cash from operations of EW is $542.30M

What is the all-time high annual cash from operations for Edwards Lifesciences Corporation?

Edwards Lifesciences Corporation all-time high annual cash from operations is $1.73B

What is Edwards Lifesciences Corporation annual cash from operations year-on-year change?

Over the past year, EW annual cash from operations has changed by -$353.50M (-39.46%)

What is Edwards Lifesciences Corporation quarterly cash from operations?

The current quarterly cash from operations of EW is $573.70M

What is the all-time high quarterly cash from operations for Edwards Lifesciences Corporation?

Edwards Lifesciences Corporation all-time high quarterly cash from operations is $778.00M

What is Edwards Lifesciences Corporation quarterly cash from operations year-on-year change?

Over the past year, EW quarterly cash from operations has changed by +$221.90M (+63.08%)

What is Edwards Lifesciences Corporation TTM cash from operations?

The current TTM cash from operations of EW is $1.02B

What is the all-time high TTM cash from operations for Edwards Lifesciences Corporation?

Edwards Lifesciences Corporation all-time high TTM cash from operations is $1.76B

What is Edwards Lifesciences Corporation TTM cash from operations year-on-year change?

Over the past year, EW TTM cash from operations has changed by +$210.40M (+26.09%)
On this page